Pharma is gaining ground in a yearslong struggle over access to federal drug discounts. Drugmakers and the federal government have historically been on opposing sides of contract pharmacy policy under 340B. But …
The peptide fad lures health tech
The next big thing after GLP-1 weight loss shots? Peptides, if digital health companies get their wish. Peptides are chains of amino acids. GLP-1s are peptides, as is insulin. But in recent years, a black …
Effectiveness of the Components of a Digital Multiple Health Behavior Change Intervention Among Individuals Seeking Help Online (Coach): Factorial Randomized Trial
Background: Extant digital multiple health behavior change interventions have shown promise in various populations; however, evidence for a broader approach among the general population is lacking. Moreover, existing interventions often contain several components but are typically assessed as a whole, meaning it remains unclear to what extent individual components contribute to intervention effects and how […]
Artificial Intelligence in Health Professions Education: Qualitative Study of Student Experiences
Background: Artificial intelligence (AI) is increasingly integrated into education and health care, raising questions about how students use these technologies and how AI influences their learning. In health education, understanding these trends is particularly important because student learning directly impacts future clinical skills. Objective: This study aimed to explore the use of AI tools by […]
RSAC 2026: AI Dominates, But Community Remains Key to Security
As AI took center stage at this year’s conference, experts debated automation, oversight and the evolving role of human intelligence in cybersecurity — despite the US government’s notable absence.
Novo and Lilly battle over GLP-1 claims only a head-to-head trial can answer
A day after Eli Lilly gained FDA approval for its obesity pill Foundayo, Novo Nordisk is fighting back with an analysis that it says shows the superiority of its own oral drug. …
Ambrosia’s sweet $100m round, and other biofinancings
Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Well-Being and Cognitive Factors Influencing Health Care Workers’ Adherence to Internet-Based Stress Management: Mixed Methods Analysis of a Nonrandomized Controlled Study
Background: High stress levels are common among health care workers (HCWs), threatening their health and workforce stability. Internet-based mobile stress management (MSM) is a promising intervention for reducing work-related stress; however, poor adherence limits effectiveness. Exploring factors influencing HCWs’ adherence may thus aid in developing optimal interventions. Objective: The research aimed to investigate (1) how […]
Drug substance maker raises prices due to energy crisis; SpectronRX gets $85M
Plus, news about Scinai Immunotherapeutics and Cardinal Health: 📈 Drug ingredients company raises prices: As the war in the Middle East continues, BASF Pharma Solutions said it is increasing the price …
Lipocine’s postpartum depression drug fails; AstraZeneca claims liver cancer win
Plus, news about Celldex and Pfizer: 📉 Lipocine’s Phase 3 fail: The Utah biotech’s stock $LPCN fell 77% after it said its oral brexanolone drug, called LPCN 1154, didn’t show …
Ethical Handling of Occupational Health and Safety Data in the Fire Service: Empirical Interview and Focus Group Study of Firefighter and Fire Service Leadership Privacy Preferences
Background: There are ongoing efforts to collect larger and higher-quality amounts of occupational health and safety data to better understand and prevent injuries and fatalities among high-risk workers, such as firefighters. Digital health systems including wearable technologies, mobile apps, or internet-based data collection platforms could collect large amounts of sensitive data, but there is little […]
Trump is preparing 100% tariffs on some drugmakers, documents show
President Donald Trump is reportedly set to implement 100% pharmaceutical tariffs as soon as Thursday, but according to a draft seen by Endpoints News, it appears they would only affect a small portion of drugmakers. …